PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Section of Infectious Diseases, Department of Medicine, Yale University School of Medicine, New Haven, CT, USA. shiv.gandhi@yale.edu.\', \'Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.\', \'Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.\', \'Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA, USA.\', \'Section of Infectious Diseases, Department of Medicine, Yale University School of Medicine, New Haven, CT, USA.\', \'Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT, USA.\', \'Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA.\', \'Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, USA.\', \'Department of Microbial Pathogenesis, Yale School of Medicine, New Haven, CT, USA.\', \'Department of Chemistry, Yale University, New Haven, CT, USA.\', \'Howard Hughes Medical Institute, Chevy Chase, MD, USA.\', \'Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.\', \'Section of Infectious Diseases, Department of Medicine, Yale University School of Medicine, New Haven, CT, USA. albert.ko@yale.edu.\', \'Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA. albert.ko@yale.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41467-022-29104-y
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 35301314
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
?:title
  • De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all